<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Regulation of microRNAs in coronary atherosclerotic plaque

dc.contributor.authorBerkan, Ocal
dc.contributor.authorArslan, Serdal
dc.contributor.authorLalem, Torkia
dc.contributor.authorZhang, Lu
dc.contributor.authorSahin, Nil Ozbilum
dc.contributor.authorAydemir, Eylem Itir
dc.contributor.authorDevaux, Yvan
dc.date.accessioned2026-10-09T21:51:47Z
dc.date.issued2019
dc.departmentYüksek İhtisas Üniversitesi
dc.description.abstractAim: Identification of microRNAs (miRNAs) associated with atherosclerosis may unravel novel therapeutic targets and biomarkers. We studied miRNAs differentially expressed between coronary atherosclerotic plaques (CAP) and healthy arteries. Materials & methods: Paired CAP and internalmammary arteries (IMA) were collected from 14 coronary artery disease patients. The miRNA profiles between diseased (CAP) and healthy (IMA) tissues were compared using microarrays and quantitative PCR. Results: Thirty-one miRNAs were differentially expressed between CAP and IMA. Among these, miR-486-5p showed a high level of regulation (12-fold), had predicted interactions with atherosclerosis-associated genes and correlated with triglyceride levels and arterial stenosis. Regulation of miR-486-5p was validated by PCR (p = 0.004). Conclusion: The miRNAs are regulated in the atherosclerotic plaque. We highlight miR-486-5p whose role in atherosclerosis requires further investigation.
dc.description.sponsorshipEuropean Union Cooperation in Science and Technology (COST) Action [EU-CardioRNA CA17129]
dc.description.sponsorshipThis paper is based upon collaboration supported by the European Union Cooperation in Science and Technology (COST) Action EU-CardioRNA CA17129.
dc.identifier.doi10.2217/epi-2019-0036
dc.identifier.endpage1397
dc.identifier.issn1750-1911
dc.identifier.issn1750-192X
dc.identifier.issue12
dc.identifier.orcid0009-0009-7361-5288
dc.identifier.orcid0000-0001-7141-6730
dc.identifier.orcid0000-0002-3921-8061
dc.identifier.orcid0000-0002-5321-8543
dc.identifier.orcid0000-0002-2889-3600
dc.identifier.pmid31596136
dc.identifier.scopus2-s2.0-85073580273
dc.identifier.scopusqualityQ3
dc.identifier.startpage1387
dc.identifier.urihttps://doi.org/10.2217/epi-2019-0036
dc.identifier.urihttps://hdl.handle.net/20.500.12794/3867
dc.identifier.volume11
dc.identifier.wosWOS:000498631700004
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.indekslendigikaynak.digerScience Citation Index Expanded (SCI-EXPANDED)
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofEpigenomics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.relation.sdgGoal-03: Good Health and Well-Being
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260922
dc.subjectAtherosclerosis
dc.subjectAtherosclerotic Plaque
dc.subjectCoronary Artery Disease
dc.subjectMicrornas
dc.titleRegulation of microRNAs in coronary atherosclerotic plaque
dc.typeArticle

Files